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Abstract 
This review focuses on the (mal)adaptive processes in atrial excitation-contraction coupling 
occurring in patients with chronic atrial fibrillation. Cellular remodeling includes shortening of the 
atrial action potential duration and effective refractory period, depressed intracellular Ca2+ 
transient, and reduced myocyte contractility. Here we summarize the current knowledge of the 
ionic bases underlying these changes. Understanding the molecular mechanisms of excitation-
contraction-coupling remodeling in the fibrillating human atria is important to identify new 
potential targets for AF therapy. 
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Introduction 
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia found in the clinical practice, 
affecting >2 million people in the United States alone (1). AF is often associated with other 
cardiovascular disorders, such as coronary artery disease, valve dysfunction, congestive heart 
failure (CHF), and is characterized by significant morbidity. A key determinant of this morbidity is 
embolic stroke (2), with loss of atrial contractility being one of the major causes of thrombus 
formation. AF is characterized by a rapid and irregular heartbeat caused when the atria quiver 
(fibrillate) erratically, sometimes faster than 200 times per minute (2). 
 Several studies have investigated the molecular and ionic mechanisms involved in the 
remodeling occurring in the atria of patients with AF, and suggest that structural, 
electrophysiological, and contractile remodeling are critical factors in the disease progression, 
i.e., they contribute to the development of a substrate that facilitates the tendency for 
persistence of AF (3, 4). Structural remodeling involves changes in atrial myocyte and tissue 
morphology (e.g., cell hypertrophy, fibrosis) (3, 5, 6).  Electrical remodeling includes changes in 
Ca2+ and K+ currents leading to shortening of the action potential (AP) duration (APD) and loss 
of APD rate-dependent adaptation (6). A growing body of experimental evidence points to 
perturbations in intracellular Ca2+ handling as important players in AF-induced atrial remodeling 
(7, 8), with intracellular Ca2+ transients (CaTs) being reduced. Myofilament protein changes in 
AF are also likely to contribute to atrial contractile dysfunction (9). However, the mechanisms 
leading to self-perpetuation of the arrhythmia and depressed cardiac contractility are yet poorly 
understood. Recently, Llach et al. have studied the basis of irregular beat-to-beat response of 
human atrial myocytes when subjected to elevations of the beating frequency (which often 
precedes cardiac arrhythmias) and suggested that stability or instability of the response was 
determined by the sarcoplasmic reticulum (SR) and L-type Ca2+ channel activities (10). 
 In this review, we present the current knowledge about the changes occurring in 
excitation-contraction (E-C) coupling that characterize the remodeled human atrial myocytes 
from patients with chronic AF (cAF), and the postulated underlying ionic mechanisms. 
Phenotypic consequences of AF on AP, CaT, and contractility 
Myocytes from cAF patients are characterized by shorter APs (Fig. 1A) and effective refractory 
period (ERP), and loss of rate adaptation of both atrial repolarization (Fig. 1A) and 
refractoriness (11-15). Typically, the human atrial AP duration at 90% repolarization (APD90) 
shortens when paced at faster frequencies, but in myocytes isolated from cAF patients this 
shortening is severely attenuated (Fig. 1A). 
 CaT amplitude is strongly depressed in myocytes from cAF patients compared to those 
from subjects in sinus rhythm (Figure 1B)(16), although the SR Ca2+ content is unaltered (16-
19). CaTs decay more slowly in cAF compared to sinus rhythm (16, 18). Elevated diastolic 
[Ca2+]i has been reported and attributed to enhanced leak of Ca2+ from the SR (17). Intracellular 
[Ca2+] measurements with aequorin light signals in atrial tissue from patients in sinus rhythm 
display a positive dependency of CaT amplitude on the pacing rate (20). Our recently published 
mathematical model of the human atrial AP and CaT recapitulated this positive rate-
dependence, and importantly showed that this is impaired when simulating cAF conditions (16). 
 Our simulations indicated that APD rate adaptation in sinus rhythm atrial cells involves 
accumulation of intracellular Na+ ([Na+]i) at high frequencies, which causes outward shifts in 
Na+/Ca2+ exchange and Na+/K+ pump currents. The model also predicted that E-C coupling 
remodeling in cAF would reduce Na+ accumulation, thus causing a blunted APD rate-dependent 
response (16).  
 Baseline force of contraction of atrial trabeculae is also reduced in human cAF by 
approximately 70% compared to patients in sinus rhythm (Figure 1C)(21-23). 
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Ionic bases of altered E-C coupling in AF 
The molecular bases of AF-induced alterations in E-C coupling are summarized in Table 1 and 
discussed in detail in the following paragraphs. E-C coupling remodeling can occur at the level 
of ion channels/transporters expression, or by modification of ion channel/transporter properties 
(for example, trafficking or phosphorylation). Furthermore, alterations of myofilament proteins 
may be involved in AF-induced hypocontractility. 
 Figure 2 depicts simulated APs and CaT for sinus rhythm and cAF myocytes (from (16)) 
and the major ionic currents that are active during the cardiac cycle, and provides a graphical 
representation of the main changes occurring in the electrophysiological and Ca2+ handling 
processes in human AF. 
Atrial Cell Morphology 
Cell capacitance of myocytes from cAF patients is greater than that of myocytes from SR 
patients, suggesting that AF cells are hypertrophied (24). In fact, cells from AF patients are both 
longer and wider than those from patients in sinus rhythm (17). Cell hypertrophy may contribute 
to cAF-induced global atrial dilation, along with changes of the extracellular matrix (with fibrosis 
and glycogen accumulation). Atrial dilation may itself have important consequences on cellular 
remodeling and alteration in protein composition and function of the atrial myocytes, as 
discussed later in this review. 
 It has recently been shown that atrial myocytes from human tissue sections exhibit 
extensive t-tubule networks (25). The presence of t-tubules in the human atria (not detected in 
isolated human atrial myocytes (26)), may play an important role in determining the spatio-
temporal properties of the intracellular CaT (25). Notably, one can speculate that t-tubules could 
be subject to remodeling and contribute to perturbed E-C coupling in cAF, as suggested in 
sheep (27) and dog (28). However, further investigations will be required to confirm this. 
Protein Kinases and Phosphatases 
Intracellular CaT is dynamically regulated via phosphorylation by protein kinase A (PKA) and 
Ca/calmodulin-dependent protein kinase II (CaMKII) of key Ca2+ handling and regulatory 
proteins, such as L-type Ca2+ channels, ryanodine receptors (RyRs), and phospholamban (PLN) 
(29, 30). In addition, sarcomere proteins and various sarcolemmal ion channels are targets of 
both PKA and CaMKII (29, 31). The phosphorylation state of target proteins is also controlled by 
serine/threonine protein-phosphatases that are differentially regulated in distinct cardiomyocyte 
microdomains. Thus, altered protein kinase and phosphatase activity may importantly contribute 
to E-C coupling remodeling in AF. Indeed, CaMKII has been found to be more expressed and 
more phosphorylated in human cAF (17, 32). Similar PKA activity was found in cAF vs. sinus 
rhythm in goats (33), but El-Armouche et al. detected a higher total activity of type 1 and type 
2A phosphatases in human cAF, causing inhomogeneous changes in protein phosphorylation in 
different cellular compartments (34). This may specifically amplify PKA and CaMKII effects on 
certain targets without having significant effects on others (e.g., higher phosphatase 
activity/lower phosphorylation in thick vs. thin myofilaments, cell membrane vs. SR) (34). Thus 
there is growing interest in the potential role of CaMKII and protein phosphatase inhibitors in 
preventing arrhythmogenic remodeling in cAF. 
Sarcolemmal Ion Channels  
INa 
The Na+ current (INa) plays a crucial role in cardiac E-C coupling by initiating the AP, and is also 
a major determinant of the cardiac AP propagation. Bosch et al. reported that INa density and 
voltage-dependence of activation were not altered in human AF (15), the steady-state 
inactivation was shifted to the right (15), and no changes were detected in mRNA levels of the 
Na+ channel gene SCN5A (35). In contrast, Sossalla et al. provided recent evidence that 
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expression of Nav1.5 and peak INa density is decreased (slightly) in the atrial myocardium of 
patients with cAF (36).  
 Although it is unclear whether altered fast INa (Fig. 2A, 2nd row) contributes to the 
electrical remodeling in human AF, it has recently been shown the late Na+ current component, 
INaL (inset), is significantly increased in cAF patients (36). Sossalla et al. (36) proposed that this 
increase could be due to the increase in neuronal Na+ channel isoforms (Nav1.1 expression is 
increased), or mediated by CaMKII, which is increased in AF (17, 32) and known to regulate INaL 
(37), or caused by oxidative stress (38, 39). However, our simulations suggested that an 
increased INaL does not contribute significantly to repolarization in cAF, where the overall APD90 
was still shorter than that in normal healthy cells (16). On the other hand, an increase in INaL 
may cause cellular Na+ and Ca2+ overload and lead to contractile dysfunction and electrical 
instability (via reverse-mode Na+/Ca2+ exchange) (29). 
ICaL 
The L-type Ca2+ current (ICaL) critically regulates E-C coupling by triggering sarcoplasmic 
reticulum (SR) Ca2+ release, and modulating AP shape and duration, i.e., maintaining the AP 
plateau (29). Reduction in ICaL density (-50% vs. sinus rhythm, Fig. 2A, 3rd row) is one of the 
most consistent electrophysiological features of electrical remodeling in human AF (as seen in 
(5, 11, 12, 16, 18, 40)). Christ et al. (40) demonstrated that decreased ICaL density in cAF is not 
accompanied by altered expression of the corresponding α1c and β2a channel subunits (although 
other studies found different results (41)), and proposed that lower basal ICaL is due to 
decreased channel phosphorylation in AF, which results from an altered ratio of protein 
kinase/phosphatase activity in favor of increased phosphatase activity. An analogous 
explanation was proposed for the blunted effect of CaMKII inhibition on ICaL in human cAF (17). 
It has been shown that blocking ICaL with nifedipine in normal human atrial cells results in an AP 
characteristic typically seen in AF (11) with respect to morphology, duration and impaired rate-
dependent adaptation, i.e., reduction in ICaL seems to be a critical component of the remodeled 
atrial electrical phenotype. However, Workman et al. found that nifedipine did not significantly 
alter ERP in sinus rhythm myocytes (although APD was shorter), thus supporting the idea that 
ICaL downregulation may not be sufficient by itself to explain the remodeled atrial electrical 
phenotype (12). 
ICaT 
There is no evidence of a T-type Ca2+ current (ICaT) in human atrial myocytes (42, 43). 
If 
The hyperpolarization-activated pacemaker current, If, has been found to be increased in human 
AF compared to sinus rhythm, at least at the mRNA level (44), and could contribute to ectopic 
atrial pacemaker activity. However, functional evidence for If involvement is lacking at present. 
Ito and IKur  
The Ca2+-independent transient outward K+ current (Ito), and the ultra-rapid delayed rectifier K+ 
current (IKur) dominate the early AP repolarization phase and confer the atrial AP a characteristic 
triangular shape. Human cAF is associated with strong reduction of Ito (Fig. 2A, 4th row) density 
(5, 12, 15, 24, 45-47) and downregulation of its channel α subunit Kv4.3 (35, 48). IKur (Fig. 2A, 
5th row) was reduced in cAF (5, 24, 45, 47, 49), paralleled by diminished expression of Kv1.5 
(35, 45, 48). However, others have reported no changes in IKur density (12, 15, 46). Inconsistent 
results about IKur function have been commented on previously by Christ et al. and attributed to 
different strategies for identification of IKur (e.g., pharmacological or with Ito-inactivating 
prepulse), and to a fraction of IKur that is not accounted for by Kv1.5 (49). The reduction in Ito and 
IKur explains the slight prolongation in earlier phases of the AP (Figure 2A, 1st row) (16, 50). 
 It has been shown that CaMKII (increased in cAF) positively regulates Ito in human atrial 
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myocytes in acute conditions, as the application of the CaMKII inhibitor KN-93 caused loss of 
channel function (32). The authors speculated that, by reducing the extent of inactivation of Ito, 
upregulation of CaMKII during atrial fibrillation reduces Ca2+ influx and therefore minimizes Ca2+ 
overload. On the other hand, CaMKII overexpression in cAF may impact channel expression, 
thus contributing to Ito downregulation, as recently shown in CaMKII-overexpressing transgenic 
mice (51). 
 Experimental evidence suggests that block of IKur enhances force of contraction of 
isolated human atrial trabeculae both in patients in sinus rhythm and AF (22, 23, 52). We have 
recently predicted that block of IKur results in prolongation and elevation of the AP plateau, which 
augments the CaT amplitude that would elicit a positive inotropic effect (16). Taken together, 
these studies suggest that IKur might be a potentially useful atrial-specific target to potentially 
counteract hypocontractility associated with cAF. A slight AP prolongation associated to IKur 
blockade may also be beneficial. 
 Caballero et al. have recently looked at differences in current density and AF-induced 
alterations in the right vs. left human atrium. They found heterogeneity in the repolarizing 
currents between the atria in sinus rhythm, and demonstrated that cAF reduced the Ito amplitude 
and density more markedly in the left than in the right atrium, thus creating a right-to-left 
gradient, whereas IKur was more markedly reduced in the right than in the left atrium, thus 
dissipating the left-to-right gradient detected in sinus rhythm (24). However, the data concerning 
intra-atrial heterogeneities in repolarizing currents in human atrial myocytes are still limited, and 
it is unclear whether and how these changes may contribute to the perpetuation of arrhythmia 
(16).  
IKs and IKr 
The delayed rectifier K+ currents have proven much harder to record and study in isolated 
human atrial cells (53). Nevertheless, their contribution is likely to be small in cells that lack an 
appreciable plateau phase (e.g., see current densities in Fig. 2A, 6th and 7th rows) (54). The 
block of the rapidly activating delayed rectifier K+ current, IKr, has been shown to prolong human 
atrial APD in the late phase of repolarization by a small amount (23), and to date no 
experimental evidence has suggested its involvement in AF-induced electrical remodeling.  
 Recently, Caballero et al. provided the first demonstration that cAF significantly 
increased the amplitude of the slow delayed rectifier K+ current, IKs, in both atria (24). They 
suggested that IKs increase could contribute to cAF-induced shortening of APD and to further 
promote fibrillatory conduction, especially with current accumulation at high frequencies.  
IK1 and IKACh 
The inwardly rectifying K+ current (IK1) primarily controls the resting potential of the cardiac cell, 
and its much lower density in atrial than in ventricular myocytes (55) confers the atrial AP a 
more depolarized resting potential (16). In cAF, increases in both current density (5, 12, 13, 45, 
56) and mRNA levels (5, 13) have been reported (Fig. 2A, 8th row). Increased IK1 causes a more 
negative resting membrane potential in cAF vs. sinus rhythm human atrial myocytes (13, 16, 
56). 
 Patients with chronic AF exhibit agonist-independent constitutive IK,ACh activity that 
contributes to the enhanced basal inward rectifier current and may result from abnormal channel 
phosphorylation by PKC (13, 56, 57). Constitutively active IK,ACh is considered to support the 
maintenance of AF, together with increased IK1, by stabilizing reentrant activity sustained by 
rotors (faster activation, less meander) (58). 
 Recently, Voigt et al. found significant left-to-right gradients in IK1 and constitutively 
active IKACh in patients with paroxysmal AF, which were dissipated in cAF, raising the idea that 
this may contribute to left-to-right dominant frequency gradients that are often more evident in 
paroxysmal AF vs. cAF (56).  
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IKATP 
The ATP-sensitive K+ (IKATP) channels generate an inward rectifying current that activates with a 
decrease in intracellular ATP concentration (59). Gene expression and electrophysiological 
studies in patients with atrial fibrillation demonstrated reduced mRNA levels of Kir6.2 (48) and 
current activation (60), but increased current was also reported (61). Interestingly, a KATP 
channel mutation has been shown to confer risk for adrenergic atrial fibrillation originating from 
the vein of Marshall (62), and it has been proposed that KATP channel deficit could play a 
broader role in the pathogenesis of electrical instability (63). It is also conceivable that metabolic 
and mechanosensitive gating of KATP channels could be altered with structural heart disease 
and atrial dilation, thus providing a substrate for the more common acquired form of atrial 
fibrillation (63). 
Ca2+ and Na+ handling 
INCX 
The Na+/Ca2+ exchanger current (INCX) is the main Ca2+ extrusion and Na+ influx pathway in 
cardiac myocytes. It extrudes 1 Ca+ in exchange for 3 Na+, thus generating an inward current 
that influences cardiac repolarization and arrhythmogenesis (29). Increased expression (18, 21, 
34) and abnormal function of INCX protein (16, 18) are implicated in human AF pathophysiology. 
An increase in INCX may be an adaptive response to cellular Ca2+ loading and contribute to 
diminish the Ca2+ overload induced by rapid atrial pacing (along with ICa downregulation). 
Indeed, the decay rate of caffeine-evoked CaT (attributable to Ca2+ removal by NCX) is shown to 
be faster in human cAF vs. sinus rhythm myocytes (16-18). Note that simulated INCX during an 
AP is smaller in AF than in sinus rhythm (Fig. 2B, 2nd row), due to the reduced CaT (Fig. 2B, 1st 
row). Na+ overload-induced Ca2+ influx via reverse-mode NCX has been implicated in Ca2+ 
overload and related arrhythmogenesis, whereas increase Ca2+ extrusion via forward-mode has 
been linked to delayed-afterdepolarizations (29, 64). Indeed, Na+ and Ca2+ loading are more 
favored at increased atrial rates (with AF). However, more studies are needed to assess 
whether delayed afterdepolarizations (DADs) are important in initiating arrhythmias in AF, and 
the underlying role of NCX in mediating them, since an increased IK1 in cAF will tend to oppose 
the occurrence of such DADs. These studies will help determine if blocking NCX represents a 
novel therapeutic strategy in suppressing arrhythmia triggers in cAF. 
INKA 
The Na+/K+ pump (NKA) is the main route of Na+ efflux in cardiac cells thus regulating 
intracellular [Na+]. By extruding 3 Na+ in exchange for 2 K+, it generates an outward current that 
is known to influence resting membrane potential and repolarization (29). Workman et al. found 
no difference in NKA pump current in myocytes from cAF patients compared to sinus rhythm, 
and concluded that INKA is not involved in AF-induced electrophysiological remodeling in patients 
(65). Our simulations show different NKA current underlying the AP (Fig. 2B, 3rd row) because of 
altered Na+ loading in cAF. Intracellular [Na+] changes may contribute to the human cAF 
phenotype, as we postulated in our modeling study (16) but have not yet measured.  
 
Ryanodine Receptors 
RyRs directly control SR Ca2+ release in cardiac muscles, activating contraction during E-C 
coupling (29). Spontaneous Ca2+-release events (Ca2+ sparks) and Ca2+ waves through leaky 
RyR channels have been reported in myocytes from cAF patients (17, 18, 66, 67) despite 
unaltered SR Ca2+ content. One potential contributor to RyR hyperactivity may be oxidative 
stress, which is known to play a critical role in AF pathophysiology (38) and increase RyR open 
probability. Neef et al. suggested that the CaMKII-dependent increase in SR Ca2+ leak caused 
by RyR hyperphosphorylation in AF is a potential arrhythmogenic mechanism (17), because 
elimination of Ca2+ via inward INCX could lead to cell depolarization and cause DADs. Voigt et al. 
measured directly single RyRs isolated from cAF patients and demonstrated a higher channel 
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open probability in cAF that responded to CaMKII inhibition (68). Thus CaMKII inhibition may 
reduce the propensity for atrial arrhythmias. 
SR Ca2+ ATP-ase and PLN 
The SR Ca2+ ATP-ase (SERCA) is responsible for pumping Ca2+ back into the SR after Ca2+ 
release (29). The endogenous inhibitor PLN regulates SERCA and releases its inhibition when 
phosphorylated by either PKA or CaMKII (29, 30). A decrease in SERCA activity, associated 
with smaller SERCA protein expression (18, 34), is evident in human cAF and explains the 
slower CaT decay compared to sinus rhythm (16, 18, 34). On the other hand, reduced inhibition 
of SERCA by hyperphosphorylated PLN (34) in cAF could help to maintain a normal SR Ca2+ 
load despite increased RyR activity.  
Ankyrin-B  
Ankyrin-B (encoded by ANK2) is an adaptor protein expressed in excitable cells that targets ion 
channels (e.g., Na+ and Ca2+ channels), transporters (e.g., NKA and NCX), and signaling 
molecules to specific membrane domains. In the heart, ankyrin-B loss-of-function mutations in 
humans lead to Long QT syndrome, AF, sinus node dysfunction and stress-induced ventricular 
arrhythmias (69). Recently, reduced ankyrin-B expression has been demonstrated in atrial 
samples of patients with paroxysmal AF, and supported an association between ankyrin-B and 
AF (70). A new potential molecular mechanism underlying ankyrin-associated AF has been 
proposed involving disrupted Cav1.3 (atrial L-type Ca2+ channels) membrane targeting in atrial 
myocytes (70). It will be interesting to further explore the role of ankyrin in cAF. 
Myofilaments 
Altered Ca2+ handling (namely, downregulation of the L-type Ca2+ channels and increased Ca2+ 
extrusion via NCX) could account for the depressed contractility in remodeled atria, but a 
reduction of the maximum force generating capacity of the myofilaments and its Ca2+-sensitivity 
may also be involved. Indeed, recent studies have highlighted the potential role of sarcomeric 
proteins in the cAF induced hypocontractility (9, 34, 71), although results are somewhat 
controversial. Compared to sinus rhythm myofibrils, cAF myofibrils exhibited reduced maximum 
rate of tension generation and maximum active tension, reduced passive tension, and increase 
in myofilament Ca2+ sensitivity (9). An earlier study did not show significant changes in 
maximum force and passive force, but did report reduced rate of tension redevelopment in cAF 
(71). One major difference between the two studies is that the former used left atrial samples 
whereas the latter used right atrial samples. 
 Altered phosphorylation state of various myofilament proteins was found in cAF vs. sinus 
rhythm. Phosphorylation of the primary sarcomere target of PKA, cTnI, was not altered in cAF 
atria (9, 34). The expression of the slow β-myosin heavy chain isoform (cMyBP-C) (9, 34, 71) 
was upregulated in cAF, and its phosphorylation levels were found significantly increased (9) or 
decreased (34). It has been suggested that discrepancies between these results may be 
explained by a decrease in cMyBP-C phosphorylation in cAF reflecting atrial dilatation rather 
than being a component of cAF (9). Another potential reason is the use of samples from the left 
atrium in the former study and from the right atrium in the latter. 
 Further studies are needed to resolve these inconsistencies. Furthermore, cell 
shortening data that are currently missing in human atrial myocytes may help in linking these 
molecular changes to functional alterations.  
It is becoming increasingly clear that studies of remodeling of human atrium by chronic AF are 
frequently and unavoidably influenced in part by multiple confounding clinical variables such as 
patient age, sex, disease history, and drug treatments. Furthermore, the changes in ion currents 
and APs should be considered to be associated with, rather than necessarily caused by, the 
chronic AF. Nevertheless, the concordance between these human chronic AF data and AF/atrial 
tachypacing-induced changes in animal models (see Table 1 in (72)) supports the view that 
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chronic AF causes atrial electrophysiological remodeling in humans. 
Consequences of ventricular dysfunction and atrial dilation on human atrial AP 
Structural, electrophysiological, mechanical, metabolic and neurohumoral remodeling 
associated with cardiac disorders, such as coronary artery disease, CHF, and left ventricular 
systolic dysfunction (LVSD) may increase AF risk (73). In atrial cells isolated from patients with 
CHF or LVSD, AP duration was either unchanged (Fig. 3A) (74, 75) or increased (Fig. 3B) (76). 
In patients in sinus rhythm with reduced left ventricular ejection fraction (< 45%) APD90 was 
shorter than in patients with higher ejection fraction (75), and there was a significant correlation 
between cellular ERP shortening and decreasing left ventricular ejection fraction (75). 
Furthermore, multivariate analysis adjusting for 10 relevant clinical covariates confirmed that 
LVSD was independently associated with atrial cellular ERP-shortening, which may, therefore, 
be expected to contribute to a predisposition to AF in these patients. The features of ionic 
remodeling in CHF or LVSD in human atrium are not fully understood. ICaL was either decreased 
in patients with coronary artery disease, aortic valve disease, or mitral valve disease (77) or 
unchanged in LVSD or CHF patients (75, 78).  Schreieck et al. found increased Ito in human 
atrial myocytes of patients with reduced left ventricular function, with no change in its voltage 
dependence or decay, but with enhanced reactivation (74). However, this Ito increase may have 
been confounded by the lower proportion of patients treated with β-blockers in the reduced LV 
function group, since such treatment is associated with decreased Ito in human atrium (79). In 
contrast, Workman et al. found that LVSD was associated with decreased Ito, a positive shift in 
its activation voltage, and no change in its decay kinetics (75).  Koumi et al. reported low resting 
membrane potential in atrial myocytes from CHF patients, possibly due to reduced density of IK1 
and IKACh (76). Workman et al. reported unchanged IK1 in LVSD (75), although Ba2+-sensitive IK1 
or IKACh were not measured. Unchanged atrial IKur has also been reported in human LVSD (74, 
75). 
 Cardiac dilatation is known to develop frequently during the course of cardiac failure 
(80). In trabeculae and myocytes taken from dilated atria the AP was shorter and the plateau 
was markedly depressed (Fig. 3C) compared to trabeculae and myocytes from non-dilated atria 
(80). However, it must be noted that the ventricular dysfunction was not quantified in these 
patients. AP changes were explained with more severely depressed ICaL compared to the 
reduction in total outward current (80).  
 Overall, the ionic bases of altered atrial function in patients with ventricular dysfunction, 
and how it predisposes to more frequent AF episodes culminating in cAF, remains poorly 
understood. 
Autonomic changes in chronic AF and related myocardial diseases 
The autonomic nervous system, and particularly the relative activities of the sympathetic 
(adrenergic) and parasympathetic (cholinergic) branches, has a major influence on the 
occurrence of AF. Furthermore, chronic AF, and certain predisposing cardiac pathologies, 
remodel atrial electrophysiological responses to catecholamines and acetylcholine and thus 
influence the electrophysiological mechanisms of AF. β-adrenergic stimulation increases human 
atrial ICaL (11, 40, 42, 81), IKur (79, 82) and If (83, 84), has no effect on IK1 (79), IKACh (85) or Ito 
(79), and has markedly different effects on connexin conductance or expression, depending 
upon their main molecular correlate; i.e. Cx40, Cx43, Cx45 (86). The increased ICaL and IKur, with 
lack of effect on other repolarizing currents, results in no net effect of β-stimulation on atrial 
APD90, as predicted by our model (16), consistent with 5 of 6 reports in human atrial cells or 
tissues (87). However, the increased ICaL markedly elevates the AP plateau (81) and, coupled 
with increased [Ca2+]i from PLN phosphorylation by adrenergic stimulation (88), favors non-
reentrant activity such as afterdepolarizations (87). Human atrial studies of α-adrenergic 
stimulation are sparse: phenylephrine inhibited IK1 (85, 89), IKACh (85) and IKur (82); also 
potentially promoting afterdepolarizations. Chronic AF consistently potentiates the effect of β-
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adrenergic stimulation to increase human atrial ICaL (11, 40, 43, 90). While this could, in theory, 
increase the propensity for afterdepolarizations in the presence of catecholamines, chronic AF 
also markedly decreases basal ICaL (6) and attenuates the effects of α-stimulation on IK1 and 
IKACh (85). Chronic AF may also cause increased atrial adrenergic innervation, “neural 
remodeling”, in patients (91). The effects of chronic AF on [Ca2+]i-responses to adrenergic 
stimulation have yet to be studied in human atrium. Data on effects of myocardial diseases that 
predispose to AF, on human atrial adrenergic responses, are equivocal: the ability of β-
stimulation to increase ICaL was attenuated (92, 93), unchanged (75) or potentiated (77) in 
association with HF or LVSD. An attenuated ICaL-increase was also reported in cells obtained 
from dilated atria from explanted hearts (78). Attenuated β-responses may involve reduced β-
receptor density or function (87). Post-operative AF was not predicted by any change in the pre-
operative atrial ICaL response to β-stimulation (94). Cholinergic elevation and increased levels of 
acetylcholine activate IKACh and also antagonize effects of catecholamines on ICaL, both 
shortening APD and ERP, thus promoting reentry (95). Also, combined adrenergic/cholinergic-
stimulation may produce “late phase EADs” (96), possibly by concurrently shortening APD and 
increasing [Ca2+]i (97). Chronic AF induces a constitutively active IKACh in human atrium (57), 
likely resulting from a PKC isoform switch (98). However, the acetylcholine-mediated increase in 
atrial IKACh (13, 57) and shortening in atrial APD (13) were each attenuated in chronic AF, and 
the cholinergic receptors GIRK1 and GIRK4 were generally downregulated (5). The attenuation 
of atrial cholinergic responses by chronic AF may be restricted to the right atrium (56). The 
ability of acetylcholine to increase IKACh and/or shorten atrial APD may be attenuated by HF, as 
shown in dogs (99). However, corroborative data from human patients with HF or LVSD are 
sparse and confounded by the presence of chronic AF (76). While much progress has been 
made, the complex and interacting influences of chronic AF and its predisposing myocardial 
pathologies on the involvement of the autonomic system in AF are yet to be resolved. 
Oxidative stress and inflammation-related changes in human AF 
Patients undergoing cardiac surgery often experience post-operative AF. It has been shown that 
these patients did not exhibit the electrophysiological remodeling seen in patients with cAF as 
far as Ca2+ and K+ currents and AP characteristics are concerned (94), whereas altered atrial 
Ca2+ handling in post-operative AF patients has not yet been studied. However, Van Wagoner et 
al. showed that patients with the highest ICaL density pre-surgery, were associated with post-
operative AF, thus indirectly suggesting a role for Ca2+ overload, mediated via 
oxidative/inflammatory stress, as a possible trigger (11). This is because increased levels of 
inflammatory markers are often recorded after cardiac surgery, and recent evidence suggests 
oxidative stress may play an important role in the pathogenesis and perpetuation of post-
operative AF (100). 
 Several studies have shown increased myocardial oxidative stress associated with AF 
(38, 101). In addition, inflammatory markers such as interleukin-6 and C-reactive protein have 
been found elevated in AF patients (101, 102). Evidences suggest that in several 
pathophysiological conditions inflammation and oxidative stress are highly interrelated, whereby 
inflammation augments oxidative stress and viceversa, and may be involved in AF 
pathogenesis. Importantly, oxidant and inflammatory mechanisms may contribute to the 
described structural, electrophysiological, and contractile remodeling that favors maintenance of 
AF (103), and thus could be considered as targets for AF-treatment, as discussed in more 
comprehensive reviews on the topic (101, 104). Inflammatory processes may contribute to atrial 
injury resulting in myocyte hypertrophy and fibrosis. Furthermore, several Ca2+ channels and 
transporters are the subject of redox modulation (105). For example, oxidative stress may play 
an important role in ICa changes, as it has been shown that S-nitrosylation of the L-type Ca2+ 
channel α subunit is increased in AF, and exogenously applied glutathione partially restores the 
AF-related ICa reduction (106). We also discussed above the potential contribution of oxidation 
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in AF-associated RyR hyperactivity. Several K+ channels (e.g., Ito (107) and IKATP) are also 
sensitive to redox state. Kv1.5 currents are inhibited by oxidation by S-nitrosylation (108), which 
may contribute to IKur suppression in AF. Redox-dependent modulation of Na+ channel activity 
has also been reported (109). Additionally, oxidative stress may affect myofilament protein 
function (38) and influence the activity of protein kinases (e.g., CaMKII (110)) and phosphatases 
that alter E-C coupling via phosphorylation of target proteins and are also redox sensitive. 
Suppressing E-C coupling remodeling with anti-inflammatory and antioxidant drugs (such as 
glucocorticoids and statins) has proven clinically useful in some cases in preventing AF 
recurrence (104). In sum, we are still limited in our understanding regarding how 
oxidative/inflammatory stress influences E-C coupling, particularly in the context of chronic AF, 
and further studies are warranted. 
Conclusions 
Chronic AF is associated with altered expression and activity of numerous sarcolemmal ion 
channels, transporters, Ca2+ handling and myofilament proteins. Understanding the ionic 
mechanisms underlying E-C coupling remodeling in fibrillating human atria, and distinguishing 
compensatory responses from maladaptive mechanisms, may allow for identification of new 
therapeutic targets to improve electrical and contractile function in cAF patients. 
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Table 1– Molecular bases of altered E-C Coupling in human AF (changes vs. sinus rhythm) 
[Modified from (16)].  
 
Cell Size/Structure 
Size Increased length and width (17) 
Cm Increased (24) 
Sarcolemmal Ion Channels 
INa No changes (15, 35) 
Steady-state inactivation shifted right (15) 
Slightly reduced current density (36) 
Late current increased (36) 
ICaL Reduced current density by ~50% (5, 11, 12, 18, 40) 
No changes in voltage dependence of activation and 
inactivation (11) 
If Increased mRNA levels (44) 
Ito Reduced density -80% in the RA -45% in the LA (5, 12, 
15, 24, 45-47) 
IKur Reduced density -55% in the RA -45% in the LA (5, 24, 
45, 47, 49) 
Unchanged (12, 15, 46) 
IKs Increased 2-fold (24) 
IK1 Upregulated +100% (5, 12, 13, 15, 45) 
IKACh Increased basal current by receptor-independent, 
constitutively active component; increased (15) or 
reduced carbachol-activated current (13, 56, 57) 
IKATP Decreased (60) 
Increased (61) 
Ca and Na handling 
INCX Upregulated (17, 18, 21, 34) 
SERCA Reduced maximal pump rate (18) and protein 
expression (34) 
PLN Enhanced PKA and CaMKII phosphorylation (34) 
Unaltered CaMKII-dependent phosphorylation (17) 
RyR Increased phosphorylation at PKA and CaMKII sites (17, 
18, 67) resulting in increased channel open probability 
(68) and SR Ca2+ leak (17, 111) 
INKA Unchanged function (65) 
Ankyrin-B Downregulated (70) 
Protein kinases and phosphatases 
CaMKII Increased expression (32) and phosphorylation (17) 
PKA Similar activity in cAF vs. sinus rhythm (34) 
PP1, PP2A Higher activity (34) 
Myofilaments Reduced maximum rate of tension generation and 
maximum active tension, reduced passive tension, and 
increase in myofilament Ca sensitivity (9) 
No changes in maximum force and passive force, 
reduced rate of tension redevelopment (71) 
Increased phosphorylation of cMyBP-C (9) 
Decreased phosphorylation of cMyBP-C (34)  
No changes in cTnI phosphorylation (9, 34) 
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Figure Legends 
Figure 1 – Altered E-C coupling in human AF. A) APs recorded at different pacing rates in a 
control human atrial myocyte (left) and in a cell from a cAF patient (right) (11). B) Intracellular 
Ca2+ transients measured in human atrial cells from sinus rhythm (left) and cAF (right) patients 
at physiological temperature. C) Twitch force measurements (22) in myocytes from sinus rhythm 
and cAF patients are shown at various doses of AVE0118 (IKur blocker). 
 
Figure 2 – Ionic bases of altered E-C coupling in AF. A) Simulated time courses of human atrial 
APs and contributing ionic currents are shown for sinus rhythm and cAF. Currents are listed on 
the left (with changes in cAF vs. sinus rhythm), and the genes encoding the channels are shown 
on the right. B) Simulated human atrial Ca2+ transients for sinus rhythm and cAF are shown with 
NCX and NKA currents (with changes in cAF vs. sinus rhythm on the left). C) Schematic 
representation of a human atrial myocyte illustrating the cAF-induced changes in Ca2+ handling 
proteins. 
 
Figure 3 – Altered atrial APs in human ventricular dysfunction. A) Atrial APs from patients with 
moderate or severe LVSD (bottom) and from patients without LVSD (top) (75). B) 
Representative AP and response to ACh in isolated atrial myocytes from HF (top) and donor 
(bottom) hearts at a stimulation frequency of 1 Hz (76). C) Representative APs from a non-
dilated (normal, left) and a dilated (right) atrium recorded at a pacing frequency of 1 Hz (80). 
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